Sun Pharmaceutical Industries informs about press release

Sun Pharmaceutical Industries has informed that it enclosed a copy of the press release titled ‘Sun Pharma receives DCGI approval to manufacture and market generic semaglutide injection in India for chronic weight management,’ which shall be released after this intimation.

The above information is a part of company’s filings submitted to BSE.